Moreover, this group described that administration of repaglinide, a pharmacological inhibitor that inhibits the interaction of ATF6 with a neuronal calcium sensor, DREAM, reduced MN loss in SOD1-ALS mice, an action that was associated with increased ATF6 processing in the spinal cord [126]. Here, ATF6 is linked to amyotrophic lateral sclerosis.